A 2% Oleosome-FGF-2 Fusion Extract Scalp Serum Improves Phototrichogram-Derived Hair Density, Anagen/Telogen Ratio, Hair Shaft Thickness and Scalp Barrier Parameters in Women with Shedding-Prone Hair: A Randomized, Single- Blind, Placebo-Controlled Pilot Study
DOI:
https://doi.org/10.56147/jbhs.3.3.153Keywords:
- Hair density,
- Telogen effluvium,
- Phototrichogram,
- Scalp serum,
- Cosmetic dermatology,
- Transepidermal water loss,
- Hair shaft thickness,
- Oleosome,
- FGF-2
Abstract
Background: Hair shedding, reduced perceived hair density, brittle hair prone to falling and scalp discomfort are common concerns in women. Objective instrumental methods such as digital phototrichogram can quantify hair density, anagen/telogen ratio and hair shaft diameter, while scalp hydration, transepidermal water loss (TEWL) and sebum measurements can characterize scalp barrier status.
Objective: To evaluate the efficacy of a 2% Oleosome-FGF-2 fusion extract scalp serum compared with placebo on hair density, anagen/telogen ratio, hair shaft thickness and scalp biophysical parameters over 84 days.
Methods: This randomized, single-blind, placebo-controlled pilot study enrolled 40 healthy female volunteers with telogen effluvium and/or brittle hair prone to falling out, ideally with dry or sensitive scalps. Participants received either 2% Oleosome-FGF-2 fusion extract Scalp Treatment (Serum A; n=20) or placebo scalp treatment (Serum B; n=20) and applied the product twice daily to the scalp for 84 days. Assessments were performed at baseline (T0), day 28 (T28), day 56 (T56) and day 84 (T84). Instrumental endpoints included anagen/telogen ratio, hair density and shaft thickness using C-CUBE Pixience digital imaging, scalp hydration by Corneometer CM825, TEWL by Nano-Tewameter TM300 and sebum level by Sebometer SM815. Clinical hair-density scoring was performed at T0 and T84 using a 5-point Likert scale aligned with Ludwig-type clinical assessment.
Resulits: At T84, Serum A increased anagen/telogen ratio by 17.0% vs. -2.6% with placebo, hair density by 33.5% vs. 7.2%, hair shaft thickness by 10.6% vs. -1.6% and scalp hydration by 22.2% vs. -2.9%. Serum A reduced TEWL by 27.2% vs.a 9.2% reduction with placebo and reduced sebum level by 30.2% vs. a 2.7% increase with placebo. Between-group comparisons favored Serum A for anagen/telogen ratio at T56 and T84, hair density at T28, T56 and T84, hair shaft thickness at T84, TEWL at T56 and T84, sebum at T56 and T84 and clinical hair-density assessment at T84. Hydration differed significantly between groups at baseline and at all post-baseline time points. Clinical hair-density scores improved in 90% of Serum A participants and 35% of placebo participants at T84.
Conclusion: In this exploratory randomized placebo-controlled pilot study, twice-daily use of a 2% Oleosome-FGF-2 fusion extract scalp serum for 84 days was associated with improved phototrichogram-derived hair density, anagen/telogen ratio, hair shaft thickness and scalp barrier parameters compared with placebo. Larger double-blind studies with prespecified primary endpoints, individual-level datasets and longer follow-up are warranted.
Downloads
References
Kligman AM (1961) Pathologic dynamics of human hair loss: I. Telogen effluvium. Arch Dermatol 83: 175-198.
Headington JT (1993) Telogen effluvium: New concepts and review. Arch Dermatol 129: 356-363.
Harrison S, Sinclair R (2002) Telogen effluvium. Clin Exp Dermatol 27: 389-395.
Malkud S (2015) Telogen effluvium: A review. J Clin Diagn Res 9: WE01-WE03.
Ramos PM, Miot HA (2015) Female pattern hair loss: A clinical and pathophysiological review. An Bras Dermatol 90: 529-543.
Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97:247-254.
Cash TF (1999) The psychosocial consequences of androgenetic alopecia: A review of the research literature. Br J Dermatol 141: 398-405.
Davis DS, Callender VD (2018) Review of quality of life studies in women with alopecia. Int J Womens Dermatol 4: 18-22.
Stenn KS, Paus R (2001) Controls of hair follicle cycling. Physiol Rev 81: 449-494.
Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341: 491-497.
Schneider MR, Schmidt-Ullrich R, Paus R (2009) The hair follicle as a dynamic miniorgan. Curr Biol 19: R132-R142.
Driskell RR, Clavel C, Rendl M, Watt FM (2011) Hair follicle dermal papilla cells at a glance. J Cell Sci 124: 1179-1182.
Rishikaysh P, Dev K, Diaz D, Qureshi WM, Filip S, et al. (2014) Signaling involved in hair follicle morphogenesis and development. Int J Mol Sci 15: 1647-1670.
Jahoda CA, Horne KA, Oliver RF (1984) Induction of hair growth by implantation of cultured dermal papilla cells. Nature 311: 560-562.
du Cros DL (1993) Fibroblast growth factor and epidermal growth factor in hair development. J Invest Dermatol 101: 106S-113S.
Ozeki M, Tabata Y (2002) Promoted growth of murine hair follicles through controlled release of basic fibroblast growth factor. Tissue Eng 8: 359-366.
Lin WH, Xiang LJ, Shi HX, Zhang J, Jiang LP, et al. (2015) Fibroblast growth factors stimulate hair growth through beta-catenin and Shh expression in C57BL/6 mice. BioMed Res Int 2015: 730139.
Hwang KA, Hwang YL, Lee MH, Kim NR, Roh SS, et al. (2012) Adenosine stimulates growth of dermal papilla and lengthens the anagen phase by increasing cysteine level via fibroblast growth factors 2 and 7 in an organ culture of mouse vibrissae hair follicles. Int J Mol Med 29: 195-201.
Hoffmann R (2001) TrichoScan: Combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo. Eur J Dermatol 11:362-368.
Hoffmann R (2003) TrichoScan: A novel tool for the analysis of hair growth in vivo. J Investig Dermatol Symp Proc 8:109-115.
Van Neste D, Trueb RM (2006) Critical study of hair growth analysis with computer-assisted methods. J Eur Acad Dermatol Venereol 20:578-583.
Dhurat R, Saraogi P (2009) Hair evaluation methods: Merits and demerits. Int J Trichology 1: 108-119.
Berardesca E, EEMCO Group (1997) EEMCO guidance for the assessment of stratum corneum hydration: Electrical methods. Skin Res Technol 3: 126-132.
Rogiers V, Balls M, Basketter D, Berardesca E, Edwards C, et al. (2001) EEMCO guidance for the assessment of transepidermal water loss (TEWL) in cosmetic sciences. Skin Pharmacol Appl Skin Physiol 14: 117-129.
Berardesca E, Loden M, Serup J, Masson P, Rodrigues LM (2018) The revised EEMCO guidance for the in vivo measurement of water in the skin. Skin Res Technol 24: 351-358.
Suchonwanit P, Triyangkulsri K, Ploydaeng M, Leerunyakul K (2019) Assessing biophysical and physiological profiles of scalp seborrheic dermatitis in the Thai population. BioMed Res Int 2019: 5128376.
Firooz A, Sadr B, Babakoohi S, Sarraf-Yazdy M, Fanian F, et al. (2012) Variation of biophysical parameters of the skin with age, gender and body region. Sci World J 2012: 386936.
Green M, Kashetsky N, Feschuk A, Maibach HI (2022) Transepidermal water loss (TEWL): Environment and pollution-A systematic review. Skin Health Dis 2: e104.
Lee YI, Kim J, Park SR, Ham S, Lee HJ, et al. (2023) Age-related changes in scalp biophysical parameters: A comparative analysis of the 20s and 50s age groups. Skin Res Technol 29: e13433.
van Rooijen GJH, Moloney MM (1995) Plant seed oil-bodies as carriers for foreign proteins. Bio/Technology 13: 72-77.
Ling H (2007) Oleosin fusion expression systems for the production of recombinant proteins. Biologia 62: 119-123.
Bhatla SC, Kaushik V, Yadav MK (2010) Use of oil bodies and oleosins in recombinant protein production and other biotechnological applications. Biotechnol Adv 28: 293-300.
Wosicka H, Cal K (2010) Targeting to the hair follicles: Current status and potential. J Dermatol Sci 57: 83-89.
World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310: 2191-2194.
Hopewell S, Chan AW, Collins GS, Hrobjartsson A, Moher D, et al. (2025) CONSORT 2025 statement: Updated guideline for reporting randomised trials. BMJ 388: e081123.
